Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482154 · ClinicalTrials.gov registry record
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 344
- Enrollment target
NCT03482154 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 344 participants.
The verdict
NCT03482154 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 344 participants
- Enrollment target
Study Summary
This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the relationship to specific outcomes.
Interventions
- PROCEDURE Hematopoietic Stem Cell Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2016-09-06 |
| Est. Completion | 2019-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03482154
The ClinicalTrials.gov registry entry for NCT03482154 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hematopoietic Stem Cell Transplant is the first listed.
NCT03482154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03482154 about?
NCT03482154 is a clinical study titled "Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population". This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the relationship to specific outcomes.
What is the current status of trial NCT03482154?
This trial is currently completed. The enrollment target is 344 participants. The study started on 2016-09-06. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03482154?
The interventions under investigation include: Hematopoietic Stem Cell Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT03482154?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.